Approach to hypersplenism due to splenic metastasis of breast cancer: A case report

Year 2012, Volume: 39 Issue: 1, 117 - 120, 01.03.2012

Mehmet Küçüköner M. Ali Kaplan Ali İnal Abdurrahman Işıkdoğan Uğur Fırat Akın Önder Feyzullah Uçmak Hakan Önder M. Recai Akdoğan

https://doi.org/10.5798/diclemedj.0921.2012.01.0108

Cited By: 1

Abstract

The most common sites for breast cancer metastasis include the bones, lungs, liver, lymph nodes, and brain. How-ever, splenic metastasis of breast cancer is extremely rare. Hypersplenism occurs as a cause of severe hemolytic anemia in carcinomas or with marked splenic enlargement related to splenic metastasis. We presented a rare case of breast cancer with splenic metastasis that was undergone splenectomy to correct cytopenia related to hypersplenism. In the light of this case, splenectomy can be beneficial in the patients with hypersplenism.

Keywords

Breast cancer, hypersplenism, splenectomy.

Approach to hypersplenism due to splenic metastasis of breast cancer: A case report

Abstract

Meme kanserinin en sık metastaz bölgeleri kemikler, akciğerler, karaciğer, lenf nodları ve beyindir. Meme kanserinin dalağa metastazı ise çok nadirdir. Hipersplenizm, karsinomalarda ciddi hemolitik aneminin bir nedeni olarak veya da-lak metastazına bağlı aşırı dalak büyümesiyle ortaya çıkar. Hipersplenizme bağlı pansitopeninin tedavisinde splenek-tomi yararlı olabilmektedir. Biz hipersplenizm ile ilişkili sitopeniyi düzeltmek için splenektomi yapılan dalak metastazlı nadir bir meme kanseri olgusunu sunduk. Bu olgunun ışığında metastatik kanserli hastalarda dalak metastazına bağlı oluşan hipersplenizm tedavisinde splenektomi faydalı olabilmektedir.

Keywords

Meme kanseri, hipersplenizm, splenektomi.

References

• Comperat E, Bardier-Dupas A, Camparo P, Capron F, Char- lotte F. Splenic metastases: clinicopathologic presentation, differential diagnosis, and pathogenesis. Arch Pathol Lab Med 2007;131(6):965-9.
• Dunn MA, Goldwein MI. Hypersplenism in advanced breast cancer: report of a patient treated with splenectomy. Cancer 1975;35(5):1449-2.
• Slavin JD, Mathews J, Spencer RP. Splenectomy for splenic metastasis from carcinoma colon. Clin Nucl Med 1986;11(7):491-2.
• Berge T. Splenic metastases: frequencies and patterns. Acta Pathol Microbiol Scand. 1974;82:499-6.
• Ishida H, Konno K, Ishida J, et al O. Isolated splenic metas- tases. J Ultrasound Med. 1997;16(11):743-9.
• Lee SS, Morgenstern L, Phillips EH, Hiatt JR, Margulies DR. Splenectomy for splenic metastases: a changing clini- cal spectrum. Am Surg 2000;66(9):837-0.
• Baranyay F. Case report: diffuse splenic metastasis of occult breast cancer with incompatible blood group antigenic de- terminants. Acta Histochem 2009;111(4):343-8.
• Nese Zehra Kavak, Birgul Karakoc. Pregnancy, primary hypersplenism and portal hypertension. T Klin J Gynecol Obst 2001;11(2):89-90.
• Piers A. C. Gatenby, Satvinder S. Mudan, Andrew C. Woth- erspoon. Splenectomy for non-haematological metastatic malignant disease. Langenbecks Arch Surg 2011 396:625- 8.